企業プロフィール
Decipher Biosciences 株価・ニュース・カタリスト
- ティッカー:
- DECI
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
DECI の終値変動に関する情報は現在取得できません。
企業概要
事業概要
Decipher Biosciences was a precision oncology diagnostics company focused on genomic tools for cancer risk and treatment selection before being acquired. Its story was rooted in molecular diagnostics and data-driven oncology decisions.
所在地とセクター分類
Decipher was headquartered in the United States and listed on NASDAQ before the acquisition. It sat in oncology diagnostics rather than therapeutics.
ビジネスモデルの特徴
The company depended on diagnostic adoption, reimbursement, and the ability to make genomic testing clinically indispensable. Investors historically watched test utilization and strategic interest.
バイオ業界での位置付け
Decipher belongs to the historical precision-oncology diagnostics category. It is best thought of as a molecular-testing business that became valuable through strategic fit.
今後のカタリスト
- Decipher Biosciences is now a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update. There is no active standalone growth story left.
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。